Cargando…

ASF1B is a Promising Prognostic Biomarker and Correlates With Immunotherapy Efficacy in Hepatocellular Carcinoma

Background: Anti-silencing function 1B (ASF1B), a histone H3-H4 chaperone, is crucial for S-phase progression and cell proliferation. Recent studies have shown that ASF1B may be used as a new proliferation marker for cancer prognosis. However, the prognostic value and effect of ASF1B on tumor cells...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Shirong, Xu, Longwen, Feng, Jinteng, Tan, Deli, Zhu, Yue, Hou, Jia, Li, Wenyuan, Lv, Kejia, Wang, Wenjuan, Jiang, Lili, Jiao, Min, Guo, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960381/ https://www.ncbi.nlm.nih.gov/pubmed/35360875 http://dx.doi.org/10.3389/fgene.2022.842351

Ejemplares similares

ncRNAs-mediated overexpression of STIL predict unfavorable prognosis and correlated with the efficacy of immunotherapy of hepatocellular carcinoma
por: Xu, Longwen, et al.
Publicado: (2023)

Pan-cancer analysis of ADAMs: A promising biomarker for prognosis and response to chemotherapy and immunotherapy
por: Ma, Bo, et al.
Publicado: (2023)

ASF1B acted as a prognostic biomarker for stomach adenocarcinoma
por: Zhao, Cailing, et al.
Publicado: (2023)

High Expression of CEMIP Correlates Poor Prognosis and the Tumur Microenvironment in Breast Cancer as a Promisingly Prognostic Biomarker
por: Dong, Xingxing, et al.
Publicado: (2021)

Mechanisms and Clinical Trials of Hepatocellular Carcinoma Immunotherapy
por: Huang, Shao-Li, et al.
Publicado: (2021)

PER1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Ovarian Cancer
por: Chen, Mali, et al.
Publicado: (2021)

Circular RNAs in extracellular vesicles: Promising candidate biomarkers for schizophrenia
por: Guo, Chuang, et al.
Publicado: (2023)

Prognostic Biomarker DDOST and Its Correlation With Immune Infiltrates in Hepatocellular Carcinoma
por: Zhu, Changyu, et al.
Publicado: (2022)

N7-Methylguanosine Genes Related Prognostic Biomarker in Hepatocellular Carcinoma
por: Regmi, Parbatraj, et al.
Publicado: (2022)

A robust CD8(+) T cell-related classifier for predicting the prognosis and efficacy of immunotherapy in stage III lung adenocarcinoma
por: Feng, Jinteng, et al.
Publicado: (2022)

TGFβ2 is a Prognostic Biomarker for Gastric Cancer and is Associated With Methylation and Immunotherapy Responses
por: Han, Bangling, et al.
Publicado: (2022)

ASF1B: A Possible Prognostic Marker, Therapeutic Target, and Predictor of Immunotherapy in Male Thyroid Carcinoma
por: Qiu, Weigang, et al.
Publicado: (2022)

Comprehensive Analysis Identified ASF1B as an Independent Prognostic Factor for HBV-Infected Hepatocellular Carcinoma
por: Wang, Xianmo, et al.
Publicado: (2022)

Pan-cancer analyses confirmed the cuproptosis-related gene FDX1 as an immunotherapy predictor and prognostic biomarker
por: Zhang, Chi, et al.
Publicado: (2022)

Pyroptosis-Related Gene to Construct Prognostic Signature and Explore Immune Microenvironment and Immunotherapy Biomarkers in Bladder Cancer
por: Zhang, Xiangyu, et al.
Publicado: (2022)

MJDs family members: Potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma
por: Zhou, Lei, et al.
Publicado: (2022)

Identification of a Ferroptosis-Related Long Noncoding RNA Prognostic Signature and Its Predictive Ability to Immunotherapy in Hepatocellular Carcinoma
por: Wang, Liang, et al.
Publicado: (2021)

Prognostic utility of TME-associated genes in pancreatic cancer
por: Nie, Yuanhua, et al.
Publicado: (2023)

Identification of biomarkers for hepatocellular carcinoma based on single cell sequencing and machine learning algorithms
por: Li, Weimin, et al.
Publicado: (2022)

Immunogenic cell death-related classifications in breast cancer identify precise immunotherapy biomarkers and enable prognostic stratification
por: Wang, Xue, et al.
Publicado: (2022)

Comprehensive Analysis to Identify the Encoded Gens of Sodium Channels as a Prognostic Biomarker in Hepatocellular Carcinoma
por: Yan, Yan, et al.
Publicado: (2022)

Integrated Bioinformatics Analysis Identifies Heat Shock Factor 2 as a Prognostic Biomarker Associated With Immune Cell Infiltration in Hepatocellular Carcinoma
por: Fan, Yumei, et al.
Publicado: (2021)

Comprehensive analysis of pan‐cancer reveals potential of ASF1B as a prognostic and immunological biomarker
por: Hu, Xinyao, et al.
Publicado: (2021)

Immunotherapy response and microenvironment provide biomarkers of immunotherapy options for patients with lung adenocarcinoma
por: Zhan, Xue, et al.
Publicado: (2022)

AURKB as a Promising Prognostic Biomarker in Hepatocellular Carcinoma
por: Xiao, Jingchuan, et al.
Publicado: (2021)

Research priorities to fill knowledge gaps on ASF seasonality that could improve the control of ASF
por: Nielsen, Søren Saxmose, et al.
Publicado: (2021)

Identification and Validation of DEPDC1B as an Independent Early Diagnostic and Prognostic Biomarker in Liver Hepatocellular Carcinoma
por: Fan, Xiaoyan, et al.
Publicado: (2022)

EIF2S2 is a novel independent prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
por: Liu, Jing, et al.
Publicado: (2022)

HOXA-AS2 may be a potential prognostic biomarker in human cancers: A meta-analysis and bioinformatics analysis
por: Zhang, Fan, et al.
Publicado: (2022)

Identification of Prognostic Biomarkers and Correlation With Immune Infiltrates in Hepatocellular Carcinoma Based on a Competing Endogenous RNA Network
por: Pu, Zhangya, et al.
Publicado: (2021)

Phosphatidylinositol glycan anchor biosynthesis, class C is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma
por: Zhao, Qian, et al.
Publicado: (2022)

An integrative analysis revealing cuproptosis-related lncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma
por: Chen, Xilang, et al.
Publicado: (2023)

Identification of novel prognostic biomarkers in the TF-enhancer-target regulatory network in hepatocellular carcinoma and immune infiltration analysis
por: Yan, Jianing, et al.
Publicado: (2023)

Identification of CD161 expression as a novel prognostic biomarker in breast cancer correlated with immune infiltration
por: Weng, Miaomiao, et al.
Publicado: (2022)

Prognostic Ferroptosis-Related lncRNA Signatures Associated With Immunotherapy and Chemotherapy Responses in Patients With Stomach Cancer
por: Lai, Donglin, et al.
Publicado: (2022)

Prognostic model and immunotherapy prediction based on molecular chaperone-related lncRNAs in lung adenocarcinoma
por: Xu, Yue, et al.
Publicado: (2022)

A necroptosis -related signature for predicting prognosis and immunotherapy in hepatocellular carcinoma
por: Fu, Xing, et al.
Publicado: (2022)

Small RNA sequencing identified miR-3180 as a potential prognostic biomarker for Chinese hepatocellular carcinoma patients
por: Sun, Libo, et al.
Publicado: (2023)

Circular RNA Foxo3: A Promising Cancer-Associated Biomarker
por: Yang, Tianli, et al.
Publicado: (2021)

Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic Insights
por: Yu, James, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ursonpc94el5vtsdi8napb7pj7